News
When Eli Lilly reports its financial results early Thursday, investors will be looking for the company to press its advantage ...
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...
Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...
Novo Nordisk stock wavered after its second-quarter earnings report early Wednesday as it vowed to cut costs amid ...
The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
7h
TipRanks on MSNEli Lilly’s New ALS Study: A Potential Game-Changer for Investors?Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...
BRANCHBURG – Eli Lilly, a multinational pharmaceutical company headquartered in Indianapolis with $45 billion in annual sales, has confirmed that it is selling its facility on Imclone Lane off Route ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results